NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

Hopeforthefuture3,

I believe this is Linda’s way of saying they are waiting on Flaskworks for a NICE submission while another funding source may be utilized in the interim (12-18 months from end of June 2024). Otherwise they would have already been working on all of this for an NICE assessment. Everything could have been done except plugging in the final numbers for quality life years in their formula for expected reimbursement. This would be done last minute to get max benefit from the surviving patients who continue to increase the average QLY benefit. Instead, she listed this NICE submission model as a future concern. Best wishes.